Mueller Matthias, Atanasov Atanas, Cima Igor, Corazza Nadia, Schoonjans Kristina, Brunner Thomas
Division of Immunopathology, Institute of Pathology, University of Bern, Murtenstrasse 31, 3010 Bern, Switzerland.
Endocrinology. 2007 Mar;148(3):1445-53. doi: 10.1210/en.2006-0591. Epub 2006 Dec 14.
Glucocorticoids are steroid hormones with important functions in development, immune regulation, and glucose metabolism. The adrenal glands are the predominant source of glucocorticoids; however, there is increasing evidence for extraadrenal glucocorticoid synthesis in thymus, brain, skin, and vascular endothelium. We recently identified intestinal epithelial cells as an important source of glucocorticoids, which regulate the activation of local intestinal immune cells. The molecular regulation of intestinal glucocorticoid synthesis is currently unexplored. In this study we investigated the transcriptional regulation of the steroidogenic enzymes P450 side-chain cleavage enzyme and 11beta-hydroxylase, and the production of corticosterone in the murine intestinal epithelial cell line mICcl2 and compared it with that in the adrenocortical cell line Y1. Surprisingly, we observed a reciprocal stimulation pattern in these two cell lines. Elevation of intracellular cAMP induced the expression of steroidogenic enzymes in Y1 cells, whereas it inhibited steroidogenesis in mICcl2 cells. In contrast, phorbol ester induced steroidogenic enzymes in intestinal epithelial cells, which was synergistically enhanced upon transfection of cells with the nuclear receptors steroidogenic factor-1 (NR5A1) and liver receptor homolog-1 (NR5A2). Finally, we observed that basal and liver receptor homolog-1/phorbol ester-induced expression of steroidogenic enzymes in mICcl2 cells was inhibited by the antagonistic nuclear receptor small heterodimer partner. We conclude that the molecular basis of glucocorticoid synthesis in intestinal epithelial cells is distinct from that in adrenal cells, most likely representing an adaptation to the local environment and different requirements.
糖皮质激素是一类在发育、免疫调节和葡萄糖代谢中具有重要功能的类固醇激素。肾上腺是糖皮质激素的主要来源;然而,越来越多的证据表明,胸腺、脑、皮肤和血管内皮中也存在肾上腺外糖皮质激素合成。我们最近发现肠上皮细胞是糖皮质激素的重要来源,其可调节局部肠道免疫细胞的激活。目前尚未探索肠道糖皮质激素合成的分子调控机制。在本研究中,我们调查了类固醇生成酶P450侧链裂解酶和11β-羟化酶的转录调控,以及小鼠肠上皮细胞系mICcl2中皮质酮的产生,并将其与肾上腺皮质细胞系Y1进行比较。令人惊讶的是,我们在这两种细胞系中观察到了一种相互刺激模式。细胞内cAMP升高诱导Y1细胞中类固醇生成酶的表达,而在mICcl2细胞中则抑制类固醇生成。相反,佛波酯可诱导肠上皮细胞中的类固醇生成酶,在用核受体类固醇生成因子-1(NR5A1)和肝脏受体同源物-1(NR5A2)转染细胞后,这种诱导作用会协同增强。最后,我们观察到,mICcl2细胞中类固醇生成酶的基础表达以及肝脏受体同源物-1/佛波酯诱导的表达受到拮抗核受体小异二聚体伴侣的抑制。我们得出结论,肠上皮细胞中糖皮质激素合成的分子基础与肾上腺细胞不同;这很可能代表了对局部环境和不同需求的一种适应。